Granulomatous disease, unspecified.
ICD-10 A31.9 is a billable code used to indicate a diagnosis of granulomatous disease, unspecified..
Granulomatous disease refers to a group of conditions characterized by the formation of granulomas, which are small areas of inflammation in tissue. These granulomas can result from various infectious and non-infectious causes, but when unspecified, it indicates that the underlying cause has not been determined. Mycobacterial infections, particularly those caused by Mycobacterium tuberculosis and non-tuberculous mycobacteria (NTM), are common triggers for granulomatous disease. Other bacterial infections, such as those caused by certain strains of Actinomyces or Nocardia, can also lead to granuloma formation. Clinically, patients may present with respiratory symptoms, systemic signs of infection, or localized symptoms depending on the affected organ. Diagnosis typically involves imaging studies, microbiological cultures, and sometimes biopsy to identify the presence of granulomas. Treatment protocols vary based on the underlying cause but often include antibiotics for bacterial infections and may require long-term therapy for mycobacterial infections. Resistance patterns, particularly in tuberculosis, are a significant concern, necessitating careful monitoring and adjustment of treatment regimens.
Detailed history of symptoms, diagnostic tests performed, and treatment plans.
Patients presenting with chronic cough, fever, and weight loss.
Ensure that all diagnostic tests and their results are documented to support the diagnosis.
Pulmonary function tests, imaging studies, and biopsy results.
Patients with suspected pulmonary granulomas due to infections.
Document the patient's smoking history and exposure to environmental factors.
Used to evaluate suspected granulomatous disease in patients with respiratory symptoms.
Document the indication for the CT scan and any findings.
Pulmonologists should ensure that imaging findings correlate with clinical symptoms.
Document the patient's symptoms, diagnostic tests performed, and any treatments initiated. Ensure that the clinical rationale for using the unspecified code is clear.
